Cyltezo®, First Interchangeable Biosimilar to Humira®, Receives Preferred Formulary Status with Optum Rx for Commercially Insured Patients prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Lupin received approval from the US FDA for its abbreviated new drug application for generic Spiriva HandiHaler. The drug is expected to add between $80m and $100m to Lupin s annual sales by FY24/25.
Mumbai, Baltimore, June21, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | June 21, 2023
Mumbai, Baltimore, June21, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | June 21, 2023